Ładuje się......
Cost-effectiveness of second curettage for treatment of low-risk non-metastatic gestational trophoblastic neoplasia
OBJECTIVE: Low-risk non-metastatic gestational trophoblastic neoplasia (GTN) has been treated with single agent chemotherapy, but second curettage is emerging as an alternative strategy with reported cure rates of 40%. We sought to estimate the cost-effectiveness of second curettage as the first lin...
Zapisane w:
| Wydane w: | Gynecol Oncol |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7293571/ https://ncbi.nlm.nih.gov/pubmed/32276791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.03.029 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|